Dachaigh › Aillse sa bhlaire › North Carolina › Durham
Sgrùdaidhean clionaigeach Aillse sa bhlaire ann an Durham, NC
Tha 20 sgrùdaidhean airson Aillse sa bhlaire a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Vanguard Study: Testing a New Way to Screen for Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
A’ fastadhÌre 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Durham VA Medical Center, Durham
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
A’ fastadhÌre 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
A’ fastadhÌre 1/2
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- Duke University Medical Center, Durham
- agus 1 a bharrachd
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
A’ fastadhÌre 1
- Biorepository and Precision Pathology Center (BRPC), Durham
- Duke Cancer Institute, Durham
- Substrate Services Core Research Support (SSCRS), Durham
DESTINY-PANTUMOUR04
A’ fastadhSgrùdadh amharc
- Research Site, Durham
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
A’ fastadhÌre 1
- Duke University Medical Center - Duke Cancer Center, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
A’ fastadhSgrùdadh amharc
- UNC- Chapel Hill, Chapel Hill · 10 mìle air falbh
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
A’ fastadhÌre 2
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
A’ fastadhÌre 2/3
- Research Site, Chapel Hill · 10 mìle air falbh
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
A’ fastadhÌre 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · 10 mìle air falbh
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
A’ fastadhÌre 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
A’ fastadhÌre 1/2
- Duke Health - Duke Cancer Center, Durham
- UNC Chapel Hill Hospital, Chapel Hill · 10 mìle air falbh
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
A’ fastadhSgrùdadh amharc
- University of North Carolina, Chapel Hill · 10 mìle air falbh
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A’ fastadhÌre 2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mìle air falbh
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill · 10 mìle air falbh
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
A’ fastadh
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mìle air falbh
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
A’ fastadhSgrùdadh amharc
- Duke University, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
A’ fastadhÌre 1
- Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mìle air falbh
Sgrùdaidhean Aillse sa bhlaire ann am bailtean eile
- New York City, NY35 sgrùdaidhean
- Nashville, TN31 sgrùdaidhean
- Houston, TX31 sgrùdaidhean
- Dallas, TX27 sgrùdaidhean
- Washington, DC26 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- Baltimore, MD24 sgrùdaidhean
- Los Angeles, CA24 sgrùdaidhean
- St. Louis, MO22 sgrùdaidhean
- Seattle, WA21 sgrùdaidhean
- Chicago, IL21 sgrùdaidhean
- Philadelphia, PA21 sgrùdaidhean
Sgrùdaidhean eile ann an Durham
- Aillse a' bhroilleach64 sgrùdaidhean
- Aillse (gach seòrsa)58 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag39 sgrùdaidhean
- Myeloma iomaill37 sgrùdaidhean
- Leukemia myeloid geur33 sgrùdaidhean
- Ailse metastatach33 sgrùdaidhean
- Aillse Prostata32 sgrùdaidhean
- Ailseachadh nan Sgamhan32 sgrùdaidhean
- Aillse colorectal28 sgrùdaidhean
- Cancer Ovarian27 sgrùdaidhean
- Leukemia Lymphocytic Cronach27 sgrùdaidhean
- Fàilligeadh a' Chridhe26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.